Telehealth offers potential to improve outcomes for anorexia treatment

Telehealth services could provide a feasible and effective platform for improving outcomes of patients with anorexia nervosa (AN), according to a study published in the International Journal of Eating Disorders.

Accessing family-based treatment for adolescents with AN and their families poses unique barriers, including social problems such as embarrassment or fear. To deliver treatment without sacrificing efficiency, researchers aimed to show the feasibility of telehealth for AN.

This study enrolled 10 adolescents meeting the DSM-5 standard for atypical AN and provided family-based treatment via telehealth. Results showed that all participants were retained for the course of treatment and improved their body mass index percentage from baseline after six months.

“These findings provide preliminary evidence that it is feasible to deliver family-based treatment via telehealth and that satisfactory clinical outcomes are achievable,” concluded first author Kristen E. Anderson MSW, LCSW, and colleagues.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.